为阿尔茨海默病风险较高的老年人开发一个公平的基于机器学习的音乐干预:算法开发和验证协议
Chelsea S Brown1,2, Luna Dziewietin3, Virginia Partridge3
1Health Sciences Integrated Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
JMIR research protocols
|August 7, 2025
概括
这项研究开发了一个智能音乐推系统,以帮助农村地区的老年人管理抑郁症并降低阿尔茨海默病 (AD) 风险. 该系统使用机器学习来个性化音乐,旨在提高数字健康干预措施的参与度和可访问性.
科学领域:
- 老年学是一门学科.
- 数字健康数字健康
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 带来了重大的公共卫生挑战,需要采取公平的干预措施,针对抑郁症等生活方式因素.
- 对文化敏感的数字健康干预对于吸引农村老年人至关重要,他们面临着独特的障碍和AD风险增加.
- 根据农村文化和需求调整干预措施对于改善阿尔茨海默病预防的可访问性和遵守性至关重要.
研究的目的:
- 开发个性化治疗音乐的智能推系统,以吸引农村老年人患阿尔茨海默病 (AD) 风险.
- 为农村老年人创造文化包容的用户人格,以了解他们对基于音乐的数字健康干预措施的需求.
- 构建机器学习 (ML) 模型,识别最佳的音乐组件,以在这个人口群体中实现参与和情感共,针对抑郁症.
主要方法:
- 在美国招募了1200名55岁以上的参与者,进行了两阶段的研究.
- 第1阶段 (n=1000):随机选择歌曲,对情绪,文化相关性和感知益处进行Likert调查.
- 第二阶段 (n=200):使用第一阶段数据开发了ML算法,将其集成到数字干预中,并评估了推的准确性和用户接受度 (目标为85%).
主要成果:
- 截至2025年6月,两个阶段的参与者招聘已经完成.
- 目前正在对所有目标进行数据分析.
- 预计结果将在2025年秋季公布.
结论:
- 该协议利用机器学习 (ML) 来提高阿尔茨海默病 (AD) 数字生活方式干预措施的公平性和可访问性.
- 这种方法旨在提供个性化的音乐治疗,改善农村老年人患AD风险的参与和坚持.
相关概念视频
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165


